Access cutting-edge anca-associated vasculitis treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access anca-associated vasculitis specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related anca-associated vasculitis treatment provided free
The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Sponsor: Amgen
Check if you qualify for this anca-associated vasculitis clinical trial in San Francisco, CA
If you're searching for anca-associated vasculitis treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced anca-associated vasculitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.